▶ Full Post Text
Herbal Dispatch (CSE: HERB | OTC Pink: LUFFF) operates as a leading **cannabis e-commerce and distribution platform** in Canada, with multiple sales avenues that drive its impressive growth trajectory. The company leverages its flagship online marketplace (herbaldispatch.com) for direct-to-consumer sales, a robust wholesale/B2B division for domestic retailers, and an expanding international export operation to federally legal markets.
# Key Sales Avenues Overview
* **Domestic Recreational Sales** — Through e-commerce direct-to-consumer and wholesale/direct delivery to retailers, primarily in British Columbia (with plans to expand to additional provinces). This includes curated small-batch craft cannabis products like flower, pre-rolls, vapes, edibles, concentrates, and more. In 2025, recreational demand surged (e.g., boosted by the BCGEU strike disrupting traditional distribution), contributing to record monthly sales like $4.1M in October and overall fiscal growth of 38% to $16.5M.
* **Medical Cannabis Sales (Domestic Focus on Veterans)** — Targeted enhancements via partnerships (e.g., Royal Canadian Legion, Veterans Affairs Canada), veteran-specific bundles, and campaigns for conditions like PTSD, pain, and anxiety. The 2026 plan targets **200% annual growth** in this high-margin segment, with KPIs like 30% YoY veteran customer acquisition and >89% retention.
* **B2B Wholesale in Canada** — Supplying licensed retailers and dispensaries nationwide, with aggressive expansion goals: 40% YoY recreational sales growth, increasing BC SKU counts from 44 to over 100, and aiming for 15% market share in BC while entering new provinces.
* **International B2B Exports** (Main Focus) — This is the high-growth engine, positioning Herbal Dispatch for massive upside. The company ships premium Canadian craft cannabis to federally legal countries, capitalizing on its network of over 300 Licensed Producers (LPs) for diverse, high-quality supply.
# Deep Dive on Exports: The Path to Massive Scale
Exports have been a game-changer, growing exponentially since initial shipments began a couple of years ago. As of recent updates, Herbal Dispatch is actively exporting to **8 countries**: Australia, Portugal, Germany, Brazil, and the Czech Republic (established markets), with strong acceleration in the EU (especially Germany as a future major driver via targeted 2026 marketing campaigns).
The company is targeting **100% year-over-year export revenue growth**, with ambitions to **triple overall export volumes by 2028**. This includes:
* Strengthening partnerships in current markets.
* Adding **2-3 new countries annually** (upcoming targets: UK, Switzerland, Costa Rica, and New Zealand).
* Investing in GMP/EU-GMP compliance and international trade shows for larger-scale deals.
Early traction was strong — back in 2023 (pre-full scale-up), the company exported **500 kg** of medical cannabis products annually, already representing about 20% of revenue at the time. With the massive LP network, GMP advancements, and new market entries (particularly Germany in 2026), Herbal Dispatch is poised to ramp up significantly.
Looking ahead, this sets the stage for achieving high-volume milestones like **exporting 500 kg per month** (or more) as recurring orders from international partners solidify. This level would represent a transformative leap from prior annual figures, driving substantial revenue acceleration given premium pricing in export markets. With domestic channels maturing and exports "growing like crazy," the company has one of the longest runways in the public cannabis sector for sharp revenue gains over the next 24-36 months.
**Small-Cap Poised to Become the Next Export King – HERB at Just $8M Market Cap**
Herbal Dispatch (CSE: HERB | OTC Pink: LUFFF) is quietly shaping up to be **one of the strongest international export stories in the entire Canadian cannabis sector** — and it’s still sitting at an absurdly low \~$8–9 million market cap.
# Why HERB Could Become the Export King
* Already actively exporting to **8 countries** (Australia • Portugal • Germany • Brazil • Czech Republic + accelerating EU volume)
* Massive supply chain advantage → **over 300 Licensed Producers** onboarded
* Extremely aggressive 2026–2028 export roadmap:
* **100%+ YoY export revenue growth** target
* **Triple total export volume by 2028**
* Adding **2–3 new countries every year** (UK, Switzerland, Costa Rica, New Zealand already named)
* Heavy investment in **GMP / EU-GMP compliance** \+ international trade shows
* Huge volume ramp already in motion → setting up to hit **500 kg per month** (and eventually much higher) in recurring export shipments
* Premium pricing in international markets + very high gross margins on export business
# The Valuation vs Growth Disconnect Is Extreme
Current market cap → **\~$8–9 million**
2025 gross sales → **$16.5 million** (already +38% YoY)
Run-rate trajectory + export explosion → **$50 million+ revenue very realistic in the next 12–24 months**
# Big M&A Precedent Just Happened
**MTL Cannabis** — just acquired by **Canopy Growth**
Deal value: \~**$125 million equity** / **$179 million enterprise value**
→ Exactly the type of fast-growing, export + medical + e-commerce profile that big players want right now
**Herbal Dispatch checks almost every box** that made MTL attractive — except HERB is:
* Much cheaper on a relative basis
* Has way more aggressive export growth baked in
* Already has the largest craft LP network in the game
# Bottom Line
Very few public cannabis companies still have:
* Single-digit million dollar market cap
* Triple-digit % export growth runway
* Clear path to **$50M+ run-rate revenue**
* Real M&A plausibility in the next 12–24 months
**HERB is one of the last remaining tiny caps that can realistically become a serious international export force.**
From this valuation?
The path to **10×–20×** is mathematically on the table if they execute even most of the export plan.
**Small cap today — potential export king tomorrow.**
# M&A Momentum: Could Herbal Dispatch Be Next?
Adding to the excitement, the Canadian cannabis sector is heating up with consolidation plays. Just last month, MTL Cannabis was acquired by Canopy Growth in a deal valued at approximately $125 million on a fully-diluted equity basis (and $179 million enterprise value), expected to close by late February 2026 and aimed at bolstering medical cannabis leadership and international supply. This move highlights big players scooping up undervalued assets with strong growth profiles—putting Herbal Dispatch squarely in the spotlight as a potential next target. With a current market cap of just $8.63 million, yet on track for explosive scaling (including projections to hit $50 million in annual revenue soon through combined domestic expansion and export ramp-up), HERB offers compelling value for acquirers looking to tap into e-commerce, veteran medical, and global B2B channels.
CEO Philip Campbell has highlighted the global opportunity, noting the company's unique position to scale exports while peers have already maxed out similar channels. If execution continues, exports could become the dominant growth driver, unlocking huge financial gains for shareholders!